SEC Form 4 · accession 0001209191-16-094219
NEOGENOMICS INC · NEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Alan Machulcz
Officer — Vice President of Operations
Period of report
Jan 28, 2016
Accepted (ET)
Jan 29, 2016 · 5:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001077183
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F1 | $6.69 | Jan 28, 2016 | A | 50,000 | A | Jan 28, 2017 | Jan 28, 2021 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1On January 28, 2016, Mr. Machulcz was granted 50,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.